Pharmaceutical & Life Sciences Recruiters

Niche Expertise, Making the Impossible, Possible

Areas of Expertise

Leaders in Industry

Leading nationwide pharmaceutical recruiters. Our pharmaceutical practice is an extremely niche recruitment area in an ever-changing industry. We focus on mid- to senior-level executives that support both the Commercial and R & D /Clinical areas for pharmaceutical manufacturers and consulting / vendors / suppliers. At Smith Hanley, we are specialized recruiters who take on hard-to-fill roles.

Pride

We take pride in understanding specific requirements for each position and the ability to identify leaders in their expert functional areas. We DO NOT take searches outside our area of expertise. Our operation, with over 53 years of combined experience, has an outstanding network and pool of candidates that allow us to target the right fit for our clients and applicants.

Results

Our focused area of recruitment supports:

  • Biostatistics & Clinical R&D
  • Market Research, Competitive Intelligence
  • Commercial Analytics
  • Pharmaceutical Sales

Our team is extremely proud as the relationships we have developed with our candidates that have developed into new clients and vice versa. Our group is dedicated to taking the time to understand the specific requirements and soft skills needed for the roles. It is only through our complete understanding of the industry and our clients’ openings that our team confidently finds the right match – and when that happens, everyone wins.

All inquiries to Eda Zullo at ezullo@smithhanley.com or 203-319-4309.

BioPharma Areas of Expertise

Commercial Analytics Careers

Sales and Marketing Careers

Market Research Careers

Clinical Careers

Our Pharma Biotech Recruiters

Eda Zullo

Division: Pharmaceutical Commercial Analytics

Nihar Parikh

Division: Biostatistics, Clinical & Medical Affairs

Nancy Victoria Ragonese

Division: BioPharma Sales & Marketing

Search Jobs

Search Pharmaceutical Jobs

Pharmaceutical News

Big pharma patent cliffs
Pharmaceutical

Big Pharma’s Patent Cliffs

EY estimates that the top twenty biopharma companies have $180 billion in sales at risk from patent expirations between now and 2028. Why isn’t their

Read More »

PMSA Annual Conference Recap

WOW! What a conference! The 2024 PMSA Annual Conference delivered on pharmaceutical industry advanced commercial analytics content and training, on industry professionals to network with

Read More »